Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | SRA Run Selector | Matt Teater | ||||||
GSE45982 |
EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation
|
61 | Matt Teater | May 13, 2013 | ||||
GSE48975 |
Genetic disruption of Ctcf destabilizes DNA methylation
|
15 |
|
Matt Teater | Jul 30, 2014 | |||
GSE71702 |
DNA Methylation Dynamics of Germinal Center B Cells Are Mediated by AID
|
50 |
|
Matt Teater | Sep 15, 2015 | |||
GSE73109 |
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq]
|
18 |
|
Matt Teater | Jul 20, 2016 | |||
GSE80351 |
Therapeutic targeting of GCB- and ABC-DLBCL by rationally designed BCL6 inhibitor
|
3 |
|
Matt Teater | Oct 12, 2016 | |||
GSE81623 |
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [ChIP-seq]
|
2 |
|
Matt Teater | Jul 20, 2016 | |||
GSE89521 |
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML
|
28 |
|
Matt Teater | Oct 24, 2019 | |||
GSE95013 |
AICDA-induced epigenetic plasticity accelerates germinal center-derived lymphomagenesis
|
88 |
|
Matt Teater | Jan 19, 2018 | |||
GSE95491 |
EZH2 enables germinal center formation through epigenetic silencing of CDKN1A and an Rb-E2F1 positive feedback loop
|
49 |
|
Matt Teater | Aug 10, 2017 | |||
GSE108293 |
Development of Specific Covalent MALT1 Inhibitors and Biomarkers for B-cell Lymphomas
|
42 |
|
Matt Teater | Nov 14, 2018 | |||
GSE130751 |
Non-oncogene addiction to SIRT3 plays a critical role in lymphomagenesis
|
63 |
|
Matt Teater | Oct 08, 2019 | |||
GSE139059 |
TBL1XR1 mutations bias germinal center B-cells towards a pro-tumorigenic memory fate
|
28 |
|
Matt Teater | Jul 02, 2020 | |||
GSE139523 |
The serine hydroxymethyltransferase-2 (SHMT2) initiates lymphoma development through epigenetic tumor suppressor silencing
|
27 |
|
Matt Teater | Apr 07, 2020 | |||
GSE142357 |
Selective inhibition of HDAC3 targets synthetic vulnerabilities and activates immune surveillance in lymphoma
|
50 |
|
Matt Teater | Jun 12, 2020 | |||
GSE143293 |
Histone 1 deficiency drives lymphomagenesis through disruption of 3D chromatin architecture
|
53 | Matt Teater | Sep 02, 2020 | ||||
GSE145061 |
Acute myeloid leukemia cells resist chemotherapy through a transient senescence-like state [RNA-seq]
|
10 |
|
Matt Teater | Mar 14, 2021 | |||
GSE146590 |
Acute myeloid leukemia cells resist chemotherapy through a transient senescence-like state [scRNA-seq]
|
2 | Matt Teater | Mar 14, 2021 | ||||
GSE146592 |
Acute myeloid leukemia cells resist chemotherapy through a transient senescence-like state [PDX]
|
15 |
|
Matt Teater | Mar 14, 2021 | |||
GSE158833 |
Translational activation of ATF4 through mitochondrial anaplerotic metabolic pathways is required for DLBCL growth and survival
|
27 |
|
Matt Teater | Sep 20, 2022 | |||
GSE167786 |
BTG1 mutation yields super-competitive B cells primed for malignant transformation
|
62 | Matt Teater | Jan 24, 2023 |